BRIEF published on 08/26/2026 at 17:50, 21 days 19 hours ago Mauna Kea Technologies: Advances in the diagnosis of digestive cancers Mauna Kea Technologies Endomicroscopy Meta-analysis NECA Digestive Cancers
BRIEF published on 08/26/2026 at 17:50, 21 days 19 hours ago Mauna Kea Technologies Highlights Meta-Analysis on Cellvizio's Clinical Impact Mauna Kea Technologies Cellvizio Meta-analysis Upper Gastrointestinal Cancer PCLE
PRESS RELEASE published on 08/26/2026 at 17:45, 21 days 19 hours ago Inside Information / Other news releases Mauna Kea Technologies announces publication of a landmark systematic review and meta-analysis reinforcing the diagnostic accuracy and clinical impact of Cellvizio in upper gastrointestinal cancer Mauna Kea Technologies Cellvizio Meta-analysis Upper Gastrointestinal Cancer Systematic Review
BRIEF published on 08/07/2026 at 17:50, 1 month 9 days ago Mauna Kea Technologies Reports Voting Rights and Share Capital Details Share Capital Voting Rights Euronext Growth AMF Regulations Mauna Kea Technologies
BRIEF published on 08/07/2026 at 17:50, 1 month 9 days ago Mauna Kea Technologies: Voting rights and share capital as of July 31, 2026 Share Capital Voting Rights AMF Euronext Growth Mauna Kea Technologies
PRESS RELEASE published on 08/07/2026 at 17:45, 1 month 9 days ago Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital Mauna Kea Technologies provides monthly information on voting rights and shares. Cellvizio platform revolutionizing medical diagnostics worldwide Voting Rights Shares Medical Diagnostics Mauna Kea Technologies Cellvizio Platform
BRIEF published on 07/16/2026 at 18:01, 2 months ago Mauna Kea Technologies to Host a Webinar on First-Half 2026 Business Activity Webinar Financial Community Business Highlights Mauna Kea Technologies Cellvizio®
BRIEF published on 07/16/2026 at 18:01, 2 months ago Mauna Kea Technologies videoconference on the first half of 2026 Shareholders Vidéo Conférence Mauna Kea Technologies Cellvizio® First Half Of 2026
PRESS RELEASE published on 07/16/2026 at 17:56, 2 months ago Inside Information / Other news releases Mauna Kea Technologies to host a webinar on July 21, 2026 to discuss its first-half business activity. Sacha Loiseau and Côme de La Tour du Pin will provide live commentary and Q&A session Medical Device Webinar Mauna Kea Technologies Cellvizio Business Activity
BRIEF published on 07/15/2026 at 19:49, 2 months 1 day ago Mauna Kea Technologies secures €4 million in funding Funding Cash Management Internationalization Cellvizio® Vester Finance
Published on 09/17/2026 at 13:00, 10 minutes ago Organto Foods Strengthens Scalable European Operating Platform and Launches AI Powered Operational Transformation
Published on 09/17/2026 at 13:00, 10 minutes ago Gold Terra Announces Fall Drilling with Three (3) Rigs Active on the Con Mine, Yellowknife, NWT
Published on 09/17/2026 at 13:00, 10 minutes ago NiobiumX Mining Inc. Appoints Athabasca Basin Discovery Geologist Erik Sehn to Board of Directors
Published on 09/17/2026 at 12:00, 1 hour 10 minutes ago Banyan Gold Intersects 1.05 g/t Gold over 52.8 metres and Bonanza-Grade Gold at Powerline Deposit, AurMac, Yukon, Canada
Published on 09/17/2026 at 10:00, 3 hours 10 minutes ago Eagle Plains Reports Additional Results from Drilling at the Don Lake Uranium Project, Saskatchewan
Published on 09/17/2026 at 13:05, 5 minutes ago Aurzen Expands Its Presence in Germany with Launch on Joybuy, Bringing EAZZE D1 and ZIP to More Consumers
Published on 09/17/2026 at 13:00, 10 minutes ago Original-Research: Smartbroker Holding AG (von GBC AG): BUY
Published on 09/17/2026 at 13:00, 10 minutes ago Medartis Group acquires M.A.R.C. Institute to establish its first surgical education center in the US
Published on 09/17/2026 at 13:00, 10 minutes ago Ascory Bank AG enters into a strategic, long-term partnership with Mount Street to deliver outsourced credit administration and surveillance
Published on 09/16/2026 at 17:45, 19 hours 25 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 6 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 19 hours ago Report on the Combined General Meeting of the 10th of September 2026
